Overview

A Study for Aggressive Adult T-cell Leukemia-lymphoma (ATLL)

Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
To test the superiority of VCAP-AMP-VECP regimen over biweekly-CHOP in aggressive ATLL in terms of survival benefit.
Phase:
Phase 3
Details
Lead Sponsor:
Japan Clinical Oncology Group
Collaborator:
Ministry of Health, Labour and Welfare, Japan
Treatments:
Lenograstim